Check patentability & draft patents in minutes with Patsnap Eureka AI!

ROCK inhibitor comprising methylnaphthalene and propanediol thiophene amide structure

A technology of allylamine and thiophene carboxylic acid, applied in the field of medicine, can solve problems such as not enough to cure diseases

Inactive Publication Date: 2018-06-08
FOSHAN SAIWEISI MEDICINE SCI & TECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As current therapies are insufficient to cure the disease, we urgently need to seek new treatments

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • ROCK inhibitor comprising methylnaphthalene and propanediol thiophene amide structure
  • ROCK inhibitor comprising methylnaphthalene and propanediol thiophene amide structure
  • ROCK inhibitor comprising methylnaphthalene and propanediol thiophene amide structure

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The synthesis of embodiment 1 compound I-1

[0028]

[0029] Step 1. Synthesis of compound IV-1

[0030] 2.07g (10mmol) of compound II-1 and 0.57g (10mmol) of compound III were dissolved in 20mL of dry THF, stirred at room temperature, and 2.48g (12mmol) of N,N'-dicyclohexylcarbodiimide (DCC) was added and 0.1 g of 4-dimethylaminopyridine (DMAP), after the addition was complete, the reaction mixture was stirred overnight at room temperature, and TLC tracking found that the reaction was complete.

[0031] The reaction mixture was carefully poured into 200mL ice water, stirred, and washed with 50mL×3CH 2 Cl 2 After extraction, the extract phases were combined, washed successively with 100 mL of 1% dilute hydrochloric acid and 100 mL of 5% brine, and dried over anhydrous sodium sulfate. The desiccant was removed by suction filtration, the filtrate was evaporated to dryness on a rotary evaporator, and the residue was purified by silica gel column chromatography to ob...

Embodiment 2

[0041] The synthesis of embodiment 2 compound 1-2

[0042]

[0043] Step 1. Synthesis of compound IV-2

[0044] 2.52g (10mmol) of compound II-1 and 0.57g (10mmol) of compound III were dissolved in 20mL of dry THF, stirred at room temperature, and 2.48g (12mmol) of N,N'-dicyclohexylcarbodiimide (DCC) was added and 0.1 g of 4-dimethylaminopyridine (DMAP), after the addition was complete, the reaction mixture was stirred overnight at room temperature, and TLC tracking found that the reaction was complete. The reaction mixture was carefully poured into 200mL ice water, stirred, and washed with 50mL×3CH 2 Cl 2 After extraction, the extract phases were combined, washed successively with 100 mL of 1% dilute hydrochloric acid and 100 mL of 5% brine, and dried over anhydrous sodium sulfate. The desiccant was removed by suction filtration, the filtrate was evaporated to dryness on a rotary evaporator, and the residue was purified by silica gel column chromatography to obtain com...

Embodiment 3

[0051] Example 3 compound in vitro inhibition of ROCK analysis

[0052]Inhibition experiments were performed by the fluorescence polarization (FP) method using a commercially available ROCK IMAP kit from Molecular Devices (Product No. R8093) and essentially according to the protocol provided by the manufacturer. The S6 ribosomal protein-derived substrate used was (Fl)-AKRRRLSSLRA, also from Molecular Devices (product number R7184). Enzyme mix of ROCKα / ROCKII was obtained from Upstate Biotechnology (product number 14-451). Briefly, all compounds were screened in 384-well plates to determine enzyme inhibition at concentrations ranging from 100 μM to 0.1 nM using serial 3-fold dilutions. Y-27632 (commercially available from Tocris Corporation) was used as a reference (0.4 μM) in order to perform the experiments. 1 μL of compound solution (each concentration) to be tested in DMSO was placed in 2 μL of enzyme solution with 10 mM Tris-HCl, 10 mM MgCl2, 0.1% BSA, 0.05% NaN3, pH 7...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines and particularly relates to a compound comprising methylnaphthalene and a propanediol thiophene amide structure, a preparation method of the compound, and application of the compound to preparation of medicines for treating sexual dysfunction, inflammatory diseases, eye diseases and diseases of the respiratory system, and the compound can serve as a ROCK inhibitor.

Description

technical field [0001] The invention belongs to the technical field of medicine. Specifically, the present invention relates to a class of compounds containing methylnaphthalene and propylene glycol thiophene amide structures, which can be used as ROCK inhibitors, their preparation methods, and their use in pharmacy. Background technique [0002] Serine / threonine protein kinase ROCK consists of two isoforms ROCK I and ROCK II in humans. ROCK I is encoded on chromosome 18, while ROCK II (also known as Rho kinase) is located on chromosome 12. Both have a molecular mass of about 160kD. The two (amino acid sequences) share 65% homology, and the homology of the kinase region is as high as 95%. Although their sequences are similar, their tissue distributions vary. The highest levels of expression of ROCK I are observed in heart, lung, and bone tissues, whereas ROCK II is mainly expressed in the brain. Recent data suggest that these two isoforms have partial functional redunda...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D333/42A61P29/00A61P15/08A61P27/02A61P11/00
CPCC07D333/42
Inventor 蔡子洋
Owner FOSHAN SAIWEISI MEDICINE SCI & TECH
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More